Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents

We reviewed 216 consecutive patients with MDS and abnormal karyotype treated with hypomethylating agents between 4/04 and 10/12. Median follow-up was 17 months. Using IWG criteria, best responses were complete response (CR) in 79 patients (37%), partial response (PR) in 4 (2%), and hematologic impro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Hematol
Egile Nagusiak: Jabbour, Elias, Strati, Paolo, Cabrero, Monica, O’Brien, Susan, Ravandi, Farhad, Bueso-Ramos, Carlos, Wei, Qiao, Hu, Jianhua, Aad, Simon Abi, Short, Nicholas J, Dinardo, Courtney, Daver, Naval, Kadia, Tapan, Wierda, William, Wei, Yue, Colla, Simona, Borthakur, Gautam, Cortes, Jorge, Estrov, Zeev, Kantarjian, Hagop, Garcia-Manero, Guillermo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5439522/
https://ncbi.nlm.nih.gov/pubmed/28076892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24650
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak